Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Los Angeles Based Ketamine Expert Dr. David Mahjoubi Announces a New 4 Day Treatment Program for Complex Regional Pain Syndrome (RSD) and Other Chronic Pain Conditions

David Mahjoubi, MD of Ketamine Healing Clinic of Los Angeles now offers a unique 4-day treatment program for patients suffering from Complex Regional Pain Syndrome (formerly known as Reflex Sympathetic Dystrophy). The IV treatment regimen is done over 4 consecutive days and uses a specially formulated blend of IV medications that target different pain receptors in the body.


News provided by

MD Internet Solutions

Nov 08, 2018, 12:00 ET

Share this article

Share toX

Share this article

Share toX


LOS ANGELES, Nov. 08, 2018 /PRNewswire-PRWeb/ -- Dr. David Mahjoubi, a pioneer of intravenous and nasal Ketamine for the treatment of Chronic Pain and Major Depression, is pleased to announce a new treatment program for chronic pain conditions, including Complex Regional Pain Syndrome (CRPS) and Regional Sympathetic Disorder (RSD). The 4-day treatment program relies on the combination of Ketamine with three other medications that block pain receptors. Dr. Mahjoubi formulated this infusion package and is the only physician to offer this unique treatment regimen for CRPS/RSD and Chronic Pain sufferers.

"It's important for patients to know that not all ketamine infusions are similar, and that choosing the right Ketamine clinic is just as important as deciding to proceed with Ketamine. Our patients come from across the nation and internationally to receive this unique and effective treatment protocol that is customized for chronic pain and CRPS sufferers," says Dr. Mahjoubi.

Patients should know not all ketamine infusions are similar, & choosing the right Ketamine clinic is just as important as deciding to proceed with Ketamine. Patients come from across the nation & internationally to receive this treatment for chronic pain & CRPS sufferers, says Dr. Mahjoubi.

Post this

Dr. David Mahjoubi is a highly skilled and experienced Board-Certified Anesthesiologist who focuses his practice solely on helping patients find relief from chronic pain and depression using a safe medication called Ketamine. Ketamine IV infusion therapy represents a convenient and effective solution to reduce or eliminate symptoms of chronic pain while avoiding opioid reliance. Dr. Mahjoubi brings elite knowledge of Ketamine use and tailors his treatment packages to meet the specific needs of each patient.

When undergoing Dr. Mahjoubi's unique infusion for chronic pain, patients report feeling significantly better immediately after the conclusion of just one of the four treatments. Complex Regional Pain Syndrome is a condition that can result in disruptive and even debilitating nerve pain symptoms. Dr. Mahjoubi's ketamine treatment program not only offers quick pain relief, but it also helps patients avoid the negative side effects of narcotic pain medications or the intrusive nature of surgery or other treatments that are often used for treating CRPS and other types of chronic pain- many of which are ineffective.

More About Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles:

David Mahjoubi, MD is a Diplomate of the American Board of Anesthesiology. He earned his Doctor of Medicine at The Chicago Medical School. Dr. Mahjoubi carries over a decade of experience with intravenous Ketamine, beginning from his residency training at the University of Southern California (USC) + Los Angeles County Medical Center. He is the author of multiple publications in the medical field and holds high honors from his educational years. Following his residency, Dr. Mahjoubi joined the Anesthesia Group at Northridge Hospital Medical Center and became the most active user of IV Ketamine for both conscious sedation and general anesthesia cases. After working at surgical centers throughout Southern California, he quickly noted the beneficial mental health effects of IV Ketamine in many patients post-procedurally. Ketamine Healing Clinic of Los Angeles was thus founded, and now provides a highly effective treatment for patients with treatment-resistant depression and chronic pain.

Ketamine Healing Clinic of Los Angeles is located at 1964 Westwood Boulevard in Los Angeles, California 90025. The clinic offers Ketamine therapy for a full menu of conditions, ranging from Depression and Alcoholism to OCD, Anxiety, PTSD and many chronic pain disorders. In addition, Dr. Mahjoubi is one of the only physicians in the country to offer a Ketamine at-home nasal spray as a convenient supplementary therapy to help maintain and extend the benefits of IV Ketamine infusions.

To learn more about Dr. Mahjoubi's treatment protocol for CRPS/RSD, please contact the Los Angeles office at (866) 987-7874, or email him at [email protected]. You may also visit the website at http://www.ketaminehealing.com.

SOURCE MD Internet Solutions

Related Links

https://www.ketaminehealing.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.